Novartis AG: Ten-fold increase in disposition capability with IBM Information Lifecycle Governance Suite
sponsored by IBM

Novartis, a multinational pharmaceutical company, was experiencing tremendous information growth and already had large amounts of electronic and physical content, including paper and lab samples.  It also had an inefficient records and retention schedule that no longer applied to the company’s information environment. Novartis required an efficient, defensible approach to retain business-critical information subject to regulatory requirement, preserve information needed for litigation and discard unnecessary data.


Check out this brief case study to learn how Novartis implemented a retention policy and schedule management system to reduce litigation and compliance risk with defensible, routine disposal of unnecessary information.  read on to discover the benefits they are enjoying from this system, including:

  • Substantially lowered storage costs
  • Increased speed of implementation
  • Ten-fold increase in ability to dispose of unnecessary information
  • And more
(THIS RESOURCE IS NO LONGER AVAILABLE.)
 
Available Resources from IBM
See what other users are reading via our Daily Top 50 Report
.

About TechTarget:

TechTarget provides enterprise IT professionals with the information they need to perform their jobs - from developing strategy, to making cost-effective IT purchase decisions and managing their organizations' IT projects - with its network of technology-specific Web sites, events and magazines

All Rights Reserved, Copyright 2000 - 2014, TechTarget | Read our Privacy Statement